Researchers have discovered that long-term glycemic control does not affect the risk of bacterial infection in type 2 ...

There is a significant Indian population affected with diabetes for both Type 1 and Type 2 Diabetes Mellitus, where Insulin ...

Mumbai: Global pharma major Lupin Limited has announced the acquisition of Huminsulin in India from Eli Lilly and Company to ...

Lupin Ltd has acquired the anti-diabetic medicine Huminsulin in India from Eli Lilly to expand its diabetes portfolio. This ...

Nilesh Gupta, Managing Director of Lupin, emphasised that this acquisition aligns with the company’s commitment to expanding ...

Lupin has acquired 'Huminsulin' in India from Eli Lilly and Company to strengthen its diabetes portfolio. The acquisition ...